Cancer Genetics Inc (NASDAQ:CGIX)

8.76
Delayed Data
As of Mar 02
 0.00 / 0.00%
Today’s Change
4.83
Today|||52-Week Range
19.99
+31.14%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Cancer Genetics Inc have a median target of 16.50, with a high estimate of 20.00 and a low estimate of 13.00. The median estimate represents a +88.36% increase from the last price of 8.76.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in Cancer Genetics Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.50
Sales
$3.7M
Reporting Date
Mar 12

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 1.96%
 
 
 
 
 
 
Growthannually 52.29%
 
 
 
 

Sales

Growthquarterly 15.00%
 
 
 
 
 
 
Growthannually 49.49%
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account